Tenax Therapeutics, Inc. (NASDAQ:TENX) Consolidated Diluted EPS Stands At $-0.5015

0

For the period ended 2015-04-30, Tenax Therapeutics, Inc. (NASDAQ:TENX) delivered annual basic consolidated EPS of $-0.5015. In terms of quarterly performance, the basic consolidated EPS was $-0.5015 for the quarter ended 2015-04-30.

What about EPS from continuing operations?

Tenax Therapeutics, Inc. (NASDAQ:TENX) produced $-0.5015 in basic EPS from continuing operations for the annual period ended 2015-04-30. For the quarter, basic EPS from continuing operations was $-0.5015 for the three-month period ended 2015-04-30.

how much did parent contribute in EPS?

Tenax Therapeutics, Inc. (NASDAQ:TENX) received basic EPS boost of $-0.5015 from its parent company for the annual period ended 2015-04-30. For quarterly metrics, basic EPS contribution from the parent company was $-0.5015 for the three-month period ended 2015-04-30.

Basic net EPS

Tenax Therapeutics, Inc. (NASDAQ:TENX) posted basic net EPS of $-0.5 for the annual period ended 2015-04-30. On quarterly basis, the basic net EPS for the quarter ended 2015-04-30 was $-0.5.

Consolidated diluted EPS

Tenax Therapeutics, Inc. (NASDAQ:TENX) produced annual consolidated diluted EPS of $-0.5015 for the period ended 2015-04-30. But consolidated diluted EPS stood at $-0.5015 for the quarter ended 2015-04-30.

Basic diluted EPS

Basic diluted EPS of $-0.5015 came from continuing operation for the annual period ended 2015-04-30. In terms of quarterly performance, diluted EPS from continuing operations was $-0.5015 for the quarter ended 2015-04-30.

Net diluted EPS

The company posted net diluted EPS of $-0.5 for the annual period ended 2015-04-30. Coming to the quarter, it posted net diluted EPS of $-0.5 for the three-month period ended 2015-04-30.

Diluted EPS from parent

Tenax Therapeutics, Inc. (NASDAQ:TENX) received diluted EPS boost of $-0.5015 from the parent company for the annual period ended 2015-04-30. For the quarter, diluted EPS from the parent was $-0.5015 for the quarter ended 2015-04-30.

For the annual period ended 2015-04-30, Tenax Therapeutics, Inc. (NASDAQ:TENX) produced net basic EPS of $-0.5. On quarterly basis, it posted basic net EPS of $-0.5, which was for the three-month period ended 2015-04-30.

The annual average of the company’s basic shares outstanding was 28.078 for the period ended 2015-04-30. The quarterly average of basic shares outstanding was 28.078 for the quarter ended 2015-04-30.

The company had diluted shares outstanding of 28.078 for the annual period ended 2015-04-30 and 28.078 for the quarterly period ended 2015-04-30.

1 Chart Pattern Every Investor Should Know

This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...

Click Here to See This Now.

(Visited 13 times, 1 visits today)